| Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study F Piscaglia, G Svegliati‐Baroni, A Barchetti, A Pecorelli, S Marinelli, ... Hepatology 63 (3), 827-838, 2016 | 602 | 2016 |
| Development and validation of a new prognostic system for patients with hepatocellular carcinoma F Farinati, A Vitale, G Spolverato, TM Pawlik, T Huo, YH Lee, AC Frigo, ... PLoS medicine 13 (4), e1002006, 2016 | 137 | 2016 |
| Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon S Petta, G Cabibbo, M Barbara, S Attardo, L Bucci, F Farinati, EG Giannini, ... Alimentary pharmacology & therapeutics 45 (1), 160-168, 2017 | 95 | 2017 |
| A meta‐analysis of single HCV‐untreated arm of studies evaluating outcomes after curative treatments of HCV‐related hepatocellular carcinoma G Cabibbo, S Petta, M Barbàra, G Missale, R Virdone, E Caturelli, ... Liver International 37 (8), 1157-1166, 2017 | 89 | 2017 |
| The evolutionary scenario of hepatocellular carcinoma in Italy: an update L Bucci, F Garuti, B Lenzi, A Pecorelli, F Farinati, EG Giannini, A Granito, ... Liver International 37 (2), 259-270, 2017 | 80 | 2017 |
| Application of the intermediate-stage subclassification to patients with untreated hepatocellular carcinoma EG Giannini, A Moscatelli, G Pellegatta, A Vitale, F Farinati, F Ciccarese, ... Official journal of the American College of Gastroenterology| ACG 111 (1), 70-77, 2016 | 76 | 2016 |
| Comparison between alcohol‐and hepatitis C virus‐related hepatocellular carcinoma: clinical presentation, treatment and outcome L Bucci, F Garuti, V Camelli, B Lenzi, F Farinati, EG Giannini, F Ciccarese, ... Alimentary pharmacology & therapeutics 43 (3), 385-399, 2016 | 73 | 2016 |
| Functional gastrointestinal and somatoform symptoms five months after SARS‐CoV‐2 infection: A controlled cohort study D Noviello, A Costantino, A Muscatello, A Bandera, D Consonni, M Vecchi, ... Neurogastroenterology & Motility 34 (2), e14187, 2022 | 68 | 2022 |
| Milan ultrasound criteria are accurate in assessing disease activity in ulcerative colitis: external validation M Allocca, E Filippi, A Costantino, S Bonovas, G Fiorino, F Furfaro, ... UEG Journal 9 (4), 438-442, 2021 | 61 | 2021 |
| The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: a multicenter cohort study A Vitale, F Farinati, TM Pawlik, AC Frigo, EG Giannini, L Napoli, ... Liver International 39 (8), 1478-1489, 2019 | 60 | 2019 |
| Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma A Pecorelli, B Lenzi, A Gramenzi, F Garuti, F Farinati, EG Giannini, ... Liver International 37 (3), 423-433, 2017 | 55 | 2017 |
| Recurrence of hepatocellular carcinoma after liver transplantation: an update A Mazzola, A Costantino, S Petta, TV Bartolotta, M Raineri, R Sacco, ... Future Oncology 11 (21), 2923-2936, 2015 | 51 | 2015 |
| Early ultrasound response and progressive transmural remission after treatment with ustekinumab in Crohn’s disease T Kucharzik, R Wilkens, MA D’agostino, G Maconi, M Le Bars, M Lahaye, ... Clinical Gastroenterology and Hepatology 21 (1), 153-163. e12, 2023 | 47 | 2023 |
| Utility of tumor burden score to stratify prognosis of patients with hepatocellular cancer: results of 4759 cases from ITA. LI. CA study group A Vitale, Q Lai, F Farinati, L Bucci, EG Giannini, L Napoli, F Ciccarese, ... Journal of Gastrointestinal Surgery 22, 859-871, 2018 | 46 | 2018 |
| Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension E Degasperi, MP Anolli, SCU Renteria, D Sambarino, M Borghi, ... Journal of hepatology 77 (6), 1525-1531, 2022 | 45 | 2022 |
| Nutrition in patients with inflammatory bowel diseases: a narrative review L Roncoroni, R Gori, L Elli, GE Tontini, L Doneda, L Norsa, M Cuomo, ... Nutrients 14 (4), 751, 2022 | 40 | 2022 |
| Restaging patients with hepatocellular carcinoma before additional treatment decisions: a multicenter cohort study A Vitale, F Farinati, G Noaro, P Burra, TM Pawlik, L Bucci, EG Giannini, ... Hepatology 68 (4), 1232-1244, 2018 | 39 | 2018 |
| COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients’ Association A Costantino, D Noviello, FS Conforti, M Aloi, A Armuzzi, F Bossa, F Ficari, ... Inflammatory Bowel Diseases, 2021 | 33 | 2021 |
| COVID-19 vaccine: a survey of hesitancy in patients with celiac disease A Costantino, M Topa, L Roncoroni, L Doneda, V Lombardo, D Stocco, ... Vaccines 9 (5), 511, 2021 | 33 | 2021 |
| Trust in telemedicine from IBD outpatients during the COVID-19 pandemic A Costantino, D Noviello, S Mazza, R Berté, F Caprioli, M Vecchi Digestive and Liver Disease 53 (3), 291-294, 2021 | 25 | 2021 |
